ARTHROSAMID
Arthrosamid is an innovative and novel type of injection treatment used to treat knee arthritis. Arthrosamid acts within the knee to help cushion the joint, reduce pain and decrease stiffness to improve knee function.
​
It integrates with the knee joint lining (synovium) to improve lubrication and protect the joint.
​
Arthrosamid is a non-biodegradable hydrogel injection consisting of 97.5% water with a 2.5% cross-linked polyacrylamide backbone and has been used for a variety of medical indications over the last 20 years.
Currently Arthrosamid® is only available in Australia via application to Canberra (TGA).
Dr Ibrahim and his team can help arrange this.
​
How is Arthrosamid® administered?
Before treatment with Arthrosamid®, you will have a local anaesthetic to numb the area around your knee. You should also be given antibiotics ahead of this to protect you from any potential risk of infection.
Your knee is cleaned prior to treatment. Arthrosamid® is then singularly injected into your knee’s synovial cavity. This is sometimes performed with the help of ultrasound. The needle is then removed and a bandaid is placed over the injection site.
Arthrosamid® distributes within the synovial fluid and begins to stick to and mesh with the synovial tissue.
How does Arthrosamid® work?
​
Arthrosamid® permanently combines with the tissue lining your knee joint, thickening it to provide a barrier.
​
It’s this unique characteristic that provides a significant reduction in your OA pain over a longer period — with one single treatment.​ Arthrosamid® combining with the synovial tissue in the knee.
Why choose Arthrosamid®?
​
No therapies have been able to satisfactorily halt or delay OA progression or provide effective, long-lasting symptomatic relief for patients with knee OA. So, until now, treatments have tended to focus on pain relief and the management.
Treatment with Arthrosamid®
remains safe and effective for its intended use three years after injection.
​
Treatment of Knee osteoarthritis symptoms through:
-
Weight loss,
-
Exercise and physiotherapy,
-
Walking aids,
-
Footwear and insoles,
-
Knee braces,
-
Oral pain relief medication,
-
Platelet Rich Plasma (PRP)
-
Viscosupplement Hyaluronic Acid (HA) injections, and — when these therapies fail
-
Joint replacement/ knee surgery
Indications, Patient Group and Usage
​​
Arthrosamid® is intended to be used for symptomatic treatment of adult patients with knee osteoarthritis
Contraindications
​
Arthrosamid® should not be injected:
-
If an active skin disease or infection is present at or near the injection site.
-
If the joint is infected or severely inflamed.
-
If the patient has previously received treatment with a different non-absorbable injectable/implant.
-
If the patient has received a knee replacement or has any foreign material in the knee.
-
If the patient has undergone knee arthroscopy within the last six months.
-
In haemophilia patients or in patients in uncontrolled anti-coagulant treatment.
​